Table 2.
The HR (95% CI) of developing abdominal obesity based on the best knots of SZn concentrations
| Male | Female | |||
|---|---|---|---|---|
| SZn (µg/dL) | 102.4-129.9 | >129.9 | 102.6-127.5 | >127.5 |
| Crude | 1.17 (0.71–1.91) | 1.58 (1.00-2.51) | 0.78 (0.58–1.06) | 0.76 (0.56–1.04) |
| Model 1 | 0.63 (0.37–1.06) | 1.08 (0.67–1.74) | 0.79 (0.58–1.08) | 0.66 (0.48–0.91) |
| Model 2 | 0.65 (0.38–1.09) | 1.14 (0.71–1.84) | 0.79 (0.58–1.08) | 0.66 (0.47–0.91) |
|
Data are HRs and 95% CI Proportional Cox regression was used; SZn < 102.4 and < 102.6 µg/dL, in male and female, was considered as reference, respectively. Model 1, adjusted for age, and baseline body weight Model 2, additionally adjusted smoking, menopause status, diabetes, and physical activity level. SZn; serum zinc | ||||